Sharpening the Preclinical Insight: Improve Clinical Relevance and Predictive Value
Sara Colombetti, Global Head Oncology Discovery Pharmacology, pharma Research and Early Development (pRED), Roche Innovation Center Zürich
We will present how the Pharmacology Group at the Roche Innovation
Center Zurich has been developing over the past years a cutting edge
mouse models platform for in vivo profiling of cancer immunotherapy
combination. First internal Ph1 data will be also presented, which
support the relevance of the pre-clinical model platform.
|
|